1. Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial 
Wail Nammas, Adam de Belder, Matti Niemelä, Jussi Sia, Hannu Romppanen, Mika Laine, Pasi P. Karjalainen 
European Journal of Internal Medicine 
Volume 37, Pages (January 2017)
DOI: /j.ejim
Copyright © 2016 European Federation of Internal Medicine Terms and Conditions

2. Fig. 1
Kaplan–Meier estimates of the primary endpoint (a composite of cardiac death, non-fatal myocardial infarction, or ischemia-driven target lesion revascularization) in the two subgroups at long-term follow-up.
MACE indicates major adverse cardiac events.
European Journal of Internal Medicine  , 43-48DOI: ( /j.ejim )
Copyright © 2016 European Federation of Internal Medicine Terms and Conditions

3. Fig. 2 Stent-based analyses of the 2 subgroups at long-term follow-up.
BAS indicates bioactive stents; EES, everolimus-eluting stents; MACE, major adverse cardiac events; MI, myocardial infarction; ST, stent thrombosis; TLR, target lesion revascularization.
European Journal of Internal Medicine  , 43-48DOI: ( /j.ejim )
Copyright © 2016 European Federation of Internal Medicine Terms and Conditions